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INTRODUCTION:  Enteropathy-associated  T-cell  lymphoma  (EATL)  is  a very  rare  malignancy.  Reasons  for
hospital  admission  are variable.
PRESENTATION OF CASE:  76  years  old  man  admitted  to emergency  service  with  sudden  and  massive
obscure  gastrointestinal  bleeding.  There  was  no  complaints  in his  history.  After  initial  evaluation,  emer-
gency  laparatomy  had  to  be  done.  Bleeding  lesion  in  proximal  jejunum  was  resected.  Histopathologically,




cells  expressed  CD3  and  CD30.  The  jejunal  mucosa  adjacent  to the  tumor  showed  effacement  of  normal
villous  architecture.
DISCUSSION:  EATL  is known  to  cause  anemia  as  a result  of chronic  bleeding.  However  in this  case,  the
bleeding  was  abundant,  irreplaceable  and  requiring  emergency  surgery.  To  our  knowledge  it  is  not
reported  previously.
CONCLUSION:  A sudden  and  massive  gastrointestinal  bleeding  can  be  the  ﬁrst  and unique  sign  of  EATL.
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. Introduction
Enteropathy-associated T-cell lymphoma (EATL) is an intestinal
umor arise from intraepithelial T-cells.1 It is a very rare disease
ith the annual incidence rate is 0.5 to 1 per million.2
EATL is strongly associated with celiac disease (CD).1,3–6
lthough CD is a long standing disease, EATL is more often pre-
eded by a short history of adult CD diagnosed after 50 years
f age. In some cases, there is no history of CD, but histopatho-
ogic features of it are found in the tissue surrounding the tumor
fter resection.1,7 In 2008, two types of EATL are introduced into
he World Health Organization (WHO) classiﬁcation of tumors
f hematopoietic and lymphoid tissues.8 The distinction between
wo types is made according to morphologic and genetic fea-
ures. Type 1 EATL is more frequently associated with celiac
isease.1,7–10
Non-speciﬁc signs and symptoms can be seen in patients with
ATL. Sometimes occult or overt gastrointestinal bleeding or bowel
erforation can be reason of hospital admission. Gastrointestinal
leeding seen in patients with lymphoma is usually insidious and
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it is manifested by iron deﬁciency anemia.1,10,11 To our knowledge,
in these patients, sudden and massive gastrointestinal hemor-
rhage has not reported previously. In this article, we report the
very unusual case of EATL which manifested by sudden and life-
threatening massive gastrointestinal bleeding, without previously
known CD.
2.  Case report
A  76-years-old male admitted to emergency service with sud-
den and severe gastrointestinal bleeding and hypovolemic shock.
There were massive hematochezia and hematemesis. There is no
history of celiac disease in his/family history. Systolic arterial blood
pressure was  60 mmHg, diastolic was  unmeasurable. The patient
was monitored and resuscitation were started immediately. Crys-
talloids and erythrocyte suspensions were given intravenously.
After the initial resuscitation hemodynamic stability was provided
and then the patient transferred to Intensive Care Unit (ICU). The
hemoglobin value increased from 4 mg/100 mL to 8 mg/100 mL.
Emergency upper and lower gastrointestinal endoscopy revealed
no lesion or active bleeding. There was blood clots in the colon
and stomach. A short time later, second severe bleeding was
observed in ICU. Despite the resuscitation and transfusions, the
Open access under CC BY-NC-SA license. patient re-entered the hypovolemic shock. We  decided to emer-
gency laparatomy in doubt.
In  exploration there was an adhesion between the transverse
mesocolon and the jejunum just after the ligament of Trietz. We
divided the adhesion. There was  a perforated lesion that had been
bleeding, on antimesenteric surface of jejunum (Fig. 1). Perforated
s Ltd. Open access under CC BY-NC-SA license. 
CASE  REPORT  –  O










oFig. 1. Perforated and actively bleeding tumor on jejunum.
rea was attached to adjecent intestine so that there was  no blood in
eritoneal cavity. We resected the lesion with margins of a few cen-
imeters of healthy jejunum in both sides. End-to-end anastomosis
as performed.
In histopathological examination, macroscopically, there were
races of bleeding and almost complete necrosis. Microscopically,
ig. 2. (a) Extensive mucosal ulceration and diffuse lymphoid inﬁltration in submucosal a
b)  Immunohistochemically, tumor cells are reactive for CD3 (immunoperoxidase, origina
orphic lymphocytes within a necrotic background (hematoxylin-eosin, original magniﬁc
riginal magniﬁcation 400×). Scale bar = 100 m.PEN  ACCESS
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intestinal mucosa showed extensive ulceration and necrosis.
Extensive necrosis made the diagnosis very hard. But the fol-
lowing ﬁndings led us to the diagnosis of EATL type 1. The
muscularis propria had abundant atypical lymphoid inﬁltrate in
diffuse pattern (Fig. 2a). Neoplastic lymphocytes were medium
to large sized cells with irregular nuclear contours and hyper-
chromatic nuclei. Some large cells with vesicular nuclei had
prominent nucleoli (Fig. 2c). The jejunal mucosa adjacent to
the tumor showed effacement of normal villous architecture
(villous atrophy, crypt hyperplasia, intraepithelial lymphocyto-
sis, pyloric metaplasia) (Fig. 3a and b). Immunohistochemically,
atypical lymphoid cells positive for CD3 (Fig. 2b) and CD30
(Fig. 2d). They were immunonegative for CD56, CD4, CD8, CD20,
ALK1. The background population was  composed of reactive B
and T lymphocytes. The intraepithelial lymphocytes in the adja-
cent mucosa were positive for CD3 and negative for CD4 and
CD8.
The patient was  discharged after surgical healing and
referred to hematology clinic in eighth day postoperatively.
The patient received combined chemotherapy regimen com-and prednisone. Since then he has been followed up by 18F-
ﬂuorodeoxyglucose positron emission tomography. The patient
is alive in twenty-fourth month after diagnosis, there were no
nd muscular layer of jejunal wall (hematoxylin-eosin, original magniﬁcation 20×).
l magniﬁcation 20×). (c) At high power magniﬁcation, variably sized atypical pleo-
ation 400×). (d) The neoplastic cells commonly express CD30 (immunoperoxidase,
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Fig. 3. (a) At low power magniﬁcation, adjacent mucosa shows blunting of
the villous architecture, crypt hyperplasia, and pyloric metaplasia (arrow)
(hematoxylin-eosin, original magniﬁcation 40×). (b) At high magniﬁcation, adjacent








hantly plasmacytic inﬂammatory inﬁltrate with scattered eosinophils in the lamina
ropria (hematoxylin-eosin, original magniﬁcation 200×). (c) Intraepithelial lym-
hocytes are positive for CD3 (immunoperoxidase, original magniﬁcation 100×).
cale bar = 100 m.
ndings suggesting recurrence or metastasis. He continues to strict
luten-free diet.. Discussion
According to the WHO  classiﬁcation of neoplasms of the
ematopoietic and lymphoid tissues, EATL is recognized that aPEN  ACCESS
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variety of T-cell lymphomas can present with intestinal involve-
ment, but not all are associated with CD.8 There are two  types of
EATL, each has different genetic, morphologic and immunologic
features. Type 1 EATL consists of medium-sized to large or pleomor-
pic cells and it is associated with CD and the HLA-DQ2 haplotype.
The cells in type 1 EATL can be immunopositive for CD3 and CD30.
Type 2 EATL consists of monomorphic small to medium sized cells.
Cells in type 2 EATL are frequently express CD56.1,7–10,12
EATL occurs predominantly in sixth decade of life and is slightly
more common in men. It is commonly localized to small intestine
especially in jejunum.1,10,12,13 EATL tumors are often multifocal and
can present with weight loss, abdominal pain, change in bowel
habit, vomiting, diarrhea or even acute abdomen due to ulceration,
obstruction or perforation.13,14 Occult or overt bleeding from gas-
trointestinal tract can also be seen in EATL.1,10,11 To our knowledge
this is the ﬁrst case of sudden and life-threatening gastrointestinal
bleeding in EATL cases.
It is difﬁcult to diagnose the EATL. Patients with EATL need a
thorough workup including video capsule enteroscopy, double bal-
loon enteroscopy, computed tomography, 18F-ﬂuorodeoxyglucose
positron emission tomography, magnetic resonance enteroclysis.1
In present case, the patient has never been any gastrointestinal
complaints. In addition, when we consider the urgency of the case,
there was  no chance to evaluate the patient preoperatively.
The source of gastrointestinal bleeding is commonly identiﬁed
by conventional upper or lower GI endoscopy. But approximately
5% of all cases remain undiagnosed.15 Obscure gastrointestinal
bleeding (OGIB) is deﬁned as bleeding of unknown origin that per-
sists or recurs after initial endoscopic evaluation. It can be overt
or occult.16 According to American Society for Gastrointestinal
Endoscopy (ASGE), in the cases of active overt OGIB, after initial
endoscopic evaluation, the prefered intervention is angiography.17
But in our case, we encountered massive and recurrent gastroin-
testinal bleeding that was  not appropriate to algorithm of ASGE.
After endoscopic evaluation in compliance with the algorithm for
obscure gastrointestinal bleeding we had to make an emergency
laparatomy. If we did not ﬁnd the source of bleeding, intraoperative
enteroscopy would be a good option.18
EATL is a serious disorder that require long-term hemathologic
treatment. However, we did not emphasize the hematholojic treat-
ment of the patient here because it is not the subject of this article.
In conclusion, EATL is a rare but very important disease with
poor prognosis and presentation of the disease is variable. In addi-
tion to what we  know up to now, this case show us a sudden and
massive gastrointestinal bleeding can be the ﬁrst and unique sign
of EATL.
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